Cargando…

A rapid near-patient RT-PCR test for suspected COVID-19: a study of the diagnostic accuracy

BACKGROUND: Management of large numbers of reverse transcriptase-polymerase chain reactions (RT-PCR) for diagnosis of coronavirus 2019 disease (COVID-19) requires robust infrastructures, located in dedicated premises with a high standard of biosafety procedures, and well-trained personnel. The handl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofman, Paul, Boutros, Jacques, Benchetrit, Didier, Benzaquen, Jonathan, Leroy, Sylvie, Tanga, Virginie, Bordone, Olivier, Allégra, Maryline, Lespinet, Virginie, Fayada, Julien, Maniel, Charlotte, Griffonnet, Jennifer, Selva, Eric, Troncone, Giancarlo, Portella, Giuseppe, Lavrut, Thibaut, Chemla, Richard, Carles, Michel, Ilié, Marius, Marquette, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263856/ https://www.ncbi.nlm.nih.gov/pubmed/34350236 http://dx.doi.org/10.21037/atm-21-690

Ejemplares similares

Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing
por: Boutros, Jacques, et al.
Publicado: (2021)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
por: Hofman, Paul, et al.
Publicado: (2022)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
por: Ilié, Marius, et al.
Publicado: (2023)

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution
por: Heeke, Simon, et al.
Publicado: (2020)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
por: Heeke, Simon, et al.
Publicado: (2018)

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay
por: Heeke, Simon, et al.
Publicado: (2021)

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
por: Lassalle, Sandra, et al.
Publicado: (2020)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
por: Heeke, Simon, et al.
Publicado: (2021)

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023)

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients
por: Long-Mira, Elodie, et al.
Publicado: (2018)

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
por: Ilie, Marius, et al.
Publicado: (2017)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
por: Hofman, Véronique, et al.
Publicado: (2022)

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients
por: Heeke, Simon, et al.
Publicado: (2019)

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
por: Pujol, Nina, et al.
Publicado: (2022)

Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

Multidisciplinary management of tracheobronchial injury
por: Boutros, Jacques, et al.
Publicado: (2022)

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
por: Long-Mira, Elodie, et al.
Publicado: (2022)

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables
por: BOUTROS, Jacques, et al.
Publicado: (2019)

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
por: Ilie, Marius, et al.
Publicado: (2017)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
por: Ilié, Marius, et al.
Publicado: (2022)

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
por: Bontoux, Christophe, et al.
Publicado: (2022)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018)

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
por: Bontoux, Christophe, et al.
Publicado: (2023)

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA
por: Washetine, Kevin, et al.
Publicado: (2018)

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014)

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
por: Washetine, Kevin, et al.
Publicado: (2018)

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023)

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France
por: Leroy, Sylvie, et al.
Publicado: (2017)

Circulating Tumor Cell Detection in Lung Cancer: But to What End?
por: Hofman, Véronique, et al.
Publicado: (2019)

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
por: Ilie, M, et al.
Publicado: (2014)

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Liu, Dingxie, et al.
Publicado: (2022)

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors
por: Normanno, Nicola, et al.
Publicado: (2023)

P2RX7B is a new theranostic marker for lung adenocarcinoma patients
por: Benzaquen, Jonathan, et al.
Publicado: (2020)

Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC
por: Sanfiorenzo, Céline, et al.
Publicado: (2013)

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
por: Ilié, Marius, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tsqomks5282v3e2m86fokr1v31